{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:47:54Z","timestamp":1769064474502,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.reumae.2025.501995","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:51:01Z","timestamp":1764795061000},"page":"501995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of rheumatoid arthritis in patients with chronic kidney disease: A real-world experience"],"prefix":"10.1016","volume":"21","author":[{"given":"Wilmer Gerardo","family":"Rojas-Zuleta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesith Guillermo","family":"Toloza-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Becerra Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Donado G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeixa Jennifer","family":"Canizales Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar Jair Felipe","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reumae.2025.501995_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard-2024-226156","article-title":"Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study","volume":"84","author":"Fukui","year":"2025","journal-title":"Ann Rheumatic Dis [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11255-019-02346-4","article-title":"Patients with rheumatoid arthritis have an increased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies","volume":"52","author":"Raksasuk","year":"2020","journal-title":"Int Urol Nephrol [Internet]"},{"issue":"19","key":"10.1016\/j.reumae.2025.501995_bib0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard-2022-223413","article-title":"American College of Rheumatology\/EULAR remission criteria for rheumatoid arthritis: 2022 revision","volume":"82","author":"Studenic","year":"2023","journal-title":"Ann Rheumatic Dis [Internet]"},{"issue":"4","key":"10.1016\/j.reumae.2025.501995_bib0025","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","year":"2025","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.reumae.2025.501995_bib0035","unstructured":"MINISTRO DE SALUD. RESOLUCION NUMERO 8430 DE 1993 [Internet]. Por la cual se establecen las normas cient\u00edficas, t\u00e9cnicas y administrativas para la investigaci\u00f3n en salud. Available from: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/ https:\/\/www.minsalud.gov.co\/sites\/rid\/lists\/bibliotecadigital\/ride\/de\/dij\/resolucion-8430-de-1993.pdf."},{"issue":"3","key":"10.1016\/j.reumae.2025.501995_bib0040","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1345\/aph.1R542","article-title":"Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study","volume":"47","author":"Russo","year":"2013","journal-title":"Ann Pharmacother [Internet]."},{"issue":"2","key":"10.1016\/j.reumae.2025.501995_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10067-012-2122-1","article-title":"Leflunomide in dialysis patients with rheumatoid arthritis\u2014a pharmacokinetic study","volume":"32","author":"Bergner","year":"2013","journal-title":"Clin Rheumatol [Internet]."},{"issue":"5","key":"10.1016\/j.reumae.2025.501995_bib0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/16.5.1087","article-title":"Severe methotrexate intoxication in a haemodialysis patient treated for rheumatoid arthritis","volume":"16","author":"Boulanger","year":"2001","journal-title":"Nephrol Dialysis Transplant [Internet]"},{"key":"10.1016\/j.reumae.2025.501995_bib0055","unstructured":"Artritis \u2013 Morbimortalidad \u2013 Demogr\u00e1fico - Cuenta de Alto Costo [Internet]. 2024 [access 2025 May 13]. Available from: https:\/\/cuentadealtocosto.org\/artritis-morbimortalidad-demografico\/."},{"issue":"10","key":"10.1016\/j.reumae.2025.501995_bib0060","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/ard-2024-225914","article-title":"Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease","volume":"83","author":"Yoshimura","year":"2024","journal-title":"Ann Rheumatic Dis [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10238-024-01360-w","article-title":"Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study","volume":"24","author":"Nakayama","year":"2024","journal-title":"Clin Exp Med [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jcph.178","article-title":"Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end\u2010stage renal disease","volume":"54","author":"Krishnaswami","year":"2014","journal-title":"J Clin Pharma [Internet]"},{"issue":"1","key":"10.1016\/j.reumae.2025.501995_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s41927-024-00446-y","article-title":"Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study","volume":"8","author":"Maeyama","year":"2024","journal-title":"BMC Rheumatol [Internet]"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:21:25Z","timestamp":1769008885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2173574325001728"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501995","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of rheumatoid arthritis in patients with chronic kidney disease: A real-world experience","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2025.501995","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501995"}}